Yuxuan Zhu Selected Research

Therapeutics

8/2023	Impact of preoperative therapy on surgical outcomes of laparoscopic total gastrectomy for gastric/gastroesophageal junction cancer.
1/2023	CAR T Cell Therapy: Remedies of Current Challenges in Design, Injection, Infiltration and Working.
1/2022	Inhibiting Cytoprotective Autophagy in Cancer Therapy: An Update on Pharmacological Small-Molecule Compounds.
1/2022	Multifunctional Gold Nanoparticles in Cancer Diagnosis and Treatment.
1/2021	Correction: A ROS-scavenging multifunctional nanoparticle for combinational therapy of diabetic nephropathy.
12/2020	A ROS-scavenging multifunctional nanoparticle for combinational therapy of diabetic nephropathy.
2/2018	Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma.
1/2018	Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy.
12/2012	Assembled nanomedicines as efficient and safe therapeutics for articular inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuxuan Zhu Research Topics

Disease

13	Neoplasms (Cancer) 03/2024 - 01/2018
4	Inflammation (Inflammations) 05/2024 - 12/2012
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2019
3	Alzheimer Disease (Alzheimer's Disease) 04/2019 - 02/2014
2	Stomach Neoplasms (Stomach Cancer) 08/2023 - 03/2023
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2019
2	Chemical and Drug Induced Liver Injury 01/2022 - 01/2021
2	Necrosis 01/2022 - 10/2020
2	Edema (Dropsy) 01/2022 - 12/2012
2	Diabetes Mellitus 12/2020 - 11/2020
2	Esophageal Squamous Cell Carcinoma 01/2019 - 01/2019
1	Hypoxia (Hypoxemia) 01/2023
1	Leukemia 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	B-Cell Leukemia (Leukemia, B Cell) 01/2023
1	Cardiotoxicity 01/2023
1	Hemorrhage 01/2022
1	Pancreatitis 01/2022
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2021
1	Hepatitis 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Hereditary Sensory and Motor Neuropathy (Dejerine Sottas Disease) 12/2020
1	Breast Neoplasms (Breast Cancer) 12/2019
1	Lymphatic Metastasis 01/2019
1	Familial Exudative Vitreoretinopathies 01/2019
1	Glioma (Gliomas) 02/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Experimental Melanoma 01/2018
1	Pathologic Processes 12/2017
1	Postoperative Pain 01/2017

Drug/Important Bio-Agent (IBA)

3	Amyloid (Amyloid Fibrils)IBA 04/2019 - 02/2014
2	AntigensIBA 04/2024 - 12/2019
2	Therapeutic UsesIBA 01/2023 - 01/2021
2	benzeneboronic acidIBA 01/2022 - 01/2021
2	Liposomes (Liposome)IBA 12/2021 - 01/2018
2	Histone Deacetylase InhibitorsIBA 01/2019 - 01/2019
1	LipopolysaccharidesIBA 05/2024
1	VaccinesIBA 04/2024
1	DNA (Deoxyribonucleic Acid)IBA 03/2024
1	Catalytic DNA (Deoxyribozyme)IBA 03/2024
1	MicroRNAs (MicroRNA)IBA 03/2024
1	matrigelIBA 12/2023
1	Transcription Factors (Transcription Factor)IBA 11/2023
1	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 03/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	abivertinibIBA 01/2023
1	N-methyladenosineIBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Contrast MediaIBA 01/2023
1	Glutathione (Reduced Glutathione)IBA 01/2023
1	IronIBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	GoldIBA 01/2022
1	PancreatinIBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	AlbuminsIBA 12/2021
1	maleimideIBA 12/2021
1	AcidsIBA 01/2021
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 12/2020
1	ceric oxide (cerium dioxide)IBA 12/2020
1	gegenqinlianIBA 11/2020
1	Interleukin-6 (Interleukin 6)IBA 10/2020
1	EnzymesIBA 10/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2020
1	CytokinesIBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 10/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2020
1	ImmunosorbentsIBA 10/2020
1	trastuzumab duocarmazineIBA 12/2019
1	Trastuzumab (Herceptin)FDA Link 12/2019
1	Immunoconjugates (Immunoconjugate)IBA 12/2019
1	Monoclonal AntibodiesIBA 12/2019
1	Peptides (Polypeptides)IBA 04/2019
1	quisinostatIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	CateninsIBA 01/2019
1	ethyl vanillinIBA 01/2019
1	polyethylene glycol-poly(lactide-co-glycolide)IBA 02/2018
1	LactoferrinIBA 02/2018
1	shikoninIBA 02/2018
1	Aurora Kinase AIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	SynucleinsIBA 12/2017

Therapy/Procedure

9	Therapeutics 08/2023 - 12/2012
2	Immunotherapy 01/2023 - 01/2023
2	Drug Therapy (Chemotherapy) 01/2022 - 12/2019
1	Gastrectomy 08/2023
1	Palliative Care (Palliative Therapy) 07/2023
1	Electrodes (Electrode) 01/2023
1	Microelectrodes 01/2023
1	Photothermal Therapy 01/2022
1	Photochemotherapy (Photodynamic Therapy) 01/2022
1	Radiotherapy 01/2022
1	Intravenous Injections 12/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2020